Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134949) titled 'An Exploratory Clinical Study of Rocbrutinib for the Treatment of Generalized Myasthenia Gravis (gMG)' on Oct. 22.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University

Condition: Generalized Myasthenia Gravis (gMG)

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-10-26

Target Sample Size: Treatment group:10;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=344007

Disclaimer: Curated by HT Syndication....